HISã®åä¼ç¤¾ãé¢ãã£ãGï½ï¼´ï½ãã©ãã«ã®ä¸æ£å©ç¨çæãé¨å±ãæä¾ãã¦ããããã«éå¶ä¼ç¤¾ã®ããã«ã«ã¤ãã¦ãGï½ï¼´ï½äºåå±ããä¸èªç¶ãªé·æ宿æ³ãHISã®åä¼ç¤¾ã®åãå«ããããï¼ï¼ï¼ï¼äººåããã¨ãã¦èª¿æ»ãã¦ãããã¨ãåããã¾ããã ãã®åé¡ã¯ãHISã®åä¼ç¤¾ï¼ç¤¾ãé¢ãã£ãGï½ï¼´ï½ç³è«ã®å¤ãã§å®¿æ³å®æ ããªããªã©ã®ä¸æ£ãçããã¦ãããã®ã§ã宿æ³å ã¯å ¨ã¦ãããã«éå¶ä¼ç¤¾ã»ï¼ªï¼¨ï¼¡ï¼´ãéå¶ããããã«ã¨ãªã£ã¦ãã¾ããã ãã®å¾ã®é¢ä¿è ã¸ã®åæã§ãJHATãéå¶ããï¼ï¼ä»¥ä¸ã®ããã«ã§æ°åæ³ãè¶ ããé·æ宿æ³ãªã©ãä¸èªç¶ãªç³è«ãHISã®åä¼ç¤¾ã®åãå«ããããï¼ï¼ï¼ï¼äººåãããGï½ï¼´ï½äºåå±ã調æ»ãã¦ãããã¨ãåããã¾ããã ãã®ãã¡æ±äº¬ã»å°æ±åºã®ããã«ã«ã¯ããããï¼ï¼ï¼äººãï¼ï¼é£æ³ããã¨ãã¦ãå½ããããã«ãæ è¡ä¼ç¤¾å´ã«ï¼åï¼ï¼ï¼ï¼ä¸åã»ã©ãè£å©ãããã¨ã¿ããã¾ããã¾ããæ±æ±åºã®ããã«ã«ã¯ããããï¼ï¼ï¼äººãï¼ï¼é£
ãã¤ãã»ãã©ã¤ãã«ã¯ã®æ½è¨ã§è£½é ããããã¡ã¤ã¶ã¼ã®æ°åã³ããã¦ã¤ã«ã¹ææççµå£æ²»çè¬ï¼2021å¹´11æ16æ¥æä¾ãè³æåçï¼ã(c)AFP PHOTO / Pfizer ã12æ15æ¥ AFPã米製è¬å¤§æãã¡ã¤ã¶ã¼ï¼Pfizerï¼ã¯14æ¥ãå社ãéçºããæ°åã³ããã¦ã¤ã«ã¹ææçã®çµå£æ²»çè¬ããã¯ã¹ãããï¼Paxlovidï¼ãã«ã¤ãã¦ãéçåãªã¹ã¯ãé«ã人ã®å ¥é¢ãæ»äº¡ã90ï¼ è¿ãæ¸å°ããããã¨ãè¨åºè©¦é¨ï¼æ²»é¨ï¼ã®æçµçµæã§ç¢ºèªãããã¨çºè¡¨ãããå¤ç°æ ªããªãã¯ãã³æ ªãã«ãå¹æãããã¨ã¿ããã¦ããã åè¬ãèªå¯ãã¦ããå½ã¯ã¾ã ãªããæçµçµæã¯ãéçåã®æããé«ãæ人2200人以ä¸ã対象ã«å®æ½ãããæ²»é¨ã«åºã¥ãããã®ã§ãå æçºè¡¨ãããæ«å®çµæãè£ä»ããå½¢ã¨ãªã£ãã å ¥é¢ãªã¹ã¯ã¯ãçºçå¾3æ¥ä»¥å ã«æä¸ããå ´åã¯89ï¼ æ¸å°ã5æ¥ä»¥å ã§ã¯88ï¼ æ¸å°ãããå½è¬ãæä¸ããã°ã«ã¼ãã§ã¯12人ãæ»äº¡ããããåè¬
ãç§ã¯ã¾ããã¨å調ãã¦çãããã¨ãã§ããªãããããæ¥æ¬ã«å¸°ããããªãçç±ã®ä¸ã¤ã§ãã ãã¨ãã®ãã¼ãã«ç©çå¦è³ã«é¸ã°ããã¢ã¡ãªã«ã»ããªã³ã¹ãã³å¤§å¦ã®çéæ·éããï¼90ï¼ãåè³æ±ºå®ç´å¾ã®è¨è ä¼è¦ã§ã®ãã®çºè¨ã«ãä¼å ´ã§ã¯å¤§ããªç¬ããèµ·ãã¾ããã ããããç§ãã¡ã¯ä¸ç·ã«ç¬ã£ã¦ãã¦ããã®ã§ããããï¼ å大ãªç§å¦è ãå£ã«ãããæ¥æ¬ã¸ã®è¦è¨ãããã®éããã¨ã°ã«ã©ãåãåãã®ãã 京é½å¤§å¦ã®ç·é·ãæ¥æ¬å¦è¡ä¼è°ã®ä¼é·ãåãããéé·é¡ã»äººé¡å¦è ã®å±±æ¥µå£½ä¸ããã«ãã®åãæ¢ããèããã¨ãã«èãã¾ãã ï¼å ±éå±ç¤¾ä¼çªçµé¨ãã¼ããã£ã¬ã¯ã¿ã¼ 西山ç©ï¼ 10æ5æ¥ãçéããã®ãã¼ãã«ç©çå¦è³åè³ãçºè¡¨ãããã¨ãæ¥æ¬ã§ã¯ãã®å績ããããã大ããªãã¥ã¼ã¹ã¨ãªãã¾ããã æ¥æ¬äººã®ãã¼ãã«è³åè³è ã¯28人ç®ï¼å¤å½ç±åå¾è ãå«ãï¼ã ãããã®ããç 究è ãåºèº«å°ã®æåªçåå½ä¸å¤®å¸ã®å°å ã®äººãã¡ãããåã³ã®å£°ãä¼ãããã¾ããã ã
ã·ã³ã¬ã¼ã»ã½ã³ã°ã©ã¤ã¿ã¼ãï½ï½ï½ï½ï¼ï¼ï¼ï¼ãï¼ï¼æ¥ãæ±äº¬ã»ææã®æ±äº¬ã¬ã¼ãã³ã·ã¢ã¿ã¼ã§è¡ã£ãå ¨å½ãã¢ã¼ã®æçµå ¬æ¼ã§çµå©ãé»æçºè¡¨ããã ã©ã¤ãã§çµå©ãé»æçºè¡¨ããaikoã¢ã³ã³ã¼ã«ã®ï¼ï¼£ã§ããå®ã¯å»å¹´çµå©ãã¦ãã¾ãããã¨é»æçºè¡¨ãçªç¶ã®åç½ã«ä¼å ´ã®ãã¡ã³ã¯é©ãã¨ç¥ç¦ã®ææã§è奮ã®ãã¤ã¼ã¨åããã ãç¸æã詳ããææã¯æè¨ããªãã£ãããä¸è¬äººã¨ã¿ãããã ãã®æ¥ã¯ããã¼ã¤ãã¬ã³ãããã¹ããã¼ããªã©ãå æ°ãã£ã±ãç±å±ããã â ï½ï½ï½ï½ï¼ãããï¼ãï¼ï¼ï¼ï¼ï¼æåï¼ï¼ï¼å¹´ï¼ï¼æï¼ï¼æ¥çã¾ããï¼ï¼æ³ã大éªã»å¹ç°å¸åºèº«ã大éªé³å¤§ç大åå¾ã®ï¼ï¼å¹´ã«ã·ã³ã°ã«ãããããã§ã¡ã¸ã£ã¼ããã¥ã¼ãã·ã³ã°ã«ï¼ï¼ä½ãã¢ã«ãã ï¼ï¼ä½ãçºè¡¨ãããè±ç«ããã«ããã ã·ãããã¼ã¤ãã¬ã³ãããåæãããã©ãã©ããªã©ãããæ²å¤æ°ãï¼®ï¼¨ï¼«ç´ ç½æåæ¦ã¯ï¼ï¼ï¼ï¼å¹´ããï¼ï¼ååºå ´ãè¡æ¶²åABã
","naka5":"<!-- BFF501 PCè¨äºä¸ï¼ä¸â¤ä¼ç»ï¼ãã¼ãï¼1541 --><!--æ ªä¾¡æ¤ç´¢ ä¸â¤ä¼ç»-->","naka6":"<!-- BFF486 PCè¨äºä¸ï¼ä¸â¥ãã¸ç·¨ï¼ãã¼ãï¼8826 --><!-- /news/esi/ichikiji/c6/default.htm -->","naka6Sp":"<!-- BFF3053 SPè¨äºä¸ï¼ä¸â¥ãã¸ç·¨ï¼ãã¼ãï¼8826 -->","adcreative72":"<!-- BFF920 åºåæ ï¼ADCREATIVE-72 ãããªç¹éã -->\n<!-- Ad BGN -->\n<!-- dfptag ï¼°ï¼£èªå°æ ï¼è¡ â ãããã -->\n<div class=\"p_infeed_list_wrapper\" id=\"p_infeed_list1\">\n <div class=\"p_infeed_list\">
建è¨æ¥ã®å注å®æ ã表ãå½ã®åºå¹¹çµ±è¨ã®èª¿æ»ã§ãå½å交éçã建è¨æ¥è ããæåºãããå注å®ç¸¾ã®ãã¼ã¿ãç¡æã§æ¸ãæãã¦ãããã¨ãããã£ããååãæ ãé½éåºçã«æ¸ãæãããããªã©ããå ¬è¡¨ããçµ±è¨ã«ã¯åãæ¥è ã®å注å®ç¸¾ããäºéè¨ä¸ããããã®ãå«ã¾ãã¦ããã建è¨æ¥ã®å注ç¶æ³ã8å¹´åããå®æ ããé大ã«ãªã£ã¦ãããçµ±è¨æ³éåã«å½ããæããããã ãã®çµ±è¨ã¯ã建è¨å·¥äºå注åæ çµ±è¨ãã§ã建è¨æ¥è ãå ¬çæ©é¢ãæ°éããå注ããå·¥äºå®ç¸¾ãéè¨ãããã®ã2020年度ã¯ç·é¡79å 5988ååãå½å ç·çç£ï¼GDPï¼ã®ç®åºã«ä½¿ãããå½äº¤çã®æ å½è ã¯ãçè«ä¸ãä¸ã¶ããã¦ããå¯è½æ§ããããã¨ãã¦ãããããã«ãæä¾çµæ¸å ±åãä¸å°ä¼æ¥æ¯æ´ãªã©ã®åºç¤è³æã«ããªã£ã¦ããã調æ»ã¯ãå ¨å½ã®æ¥è ããç´1ä¸2å社ãæ½åºããå注å®ç¸¾ã®å ±åãå½äº¤çãæ¯æåãã¦éè¨ãå ¬è¡¨ããã å½äº¤çã«ããã¨ãæ¸ãæãã¦ããã®ã¯ãæ¥è ãå注å®ç¸¾ãæ¯æè¨ããæåºãã
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}